Discovery ofSTX-721, a Covalent, Potent, and HighlyMutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatmentof Non-Small Cell Lung Cancer. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.